title: Toxicological management of chlorophacinone poisoning.
abstract: A 33-year-old man was admitted 8 hours after voluntary ingestion of 1875 mg of chlorophacinone (C'Operat 750 mL). The examination revealed excitation and nausea, with a normal prothrombin index (PI). Comprehensive testing for abused and therapeutic drugs in blood confirmed chlorophacinone (maximum plasma level: 27.6 mg/L), an antivitamin K (AVK) rodenticide. In a search for easy toxicological management of chlorophacinone poisoning treated by phytomenadione and a cytochrome P450 inducer (phenobarbital), PI and chlorophacinone plasma levels were monitored concomitantly during 17 days. A simple HPLC procedure for the determination of chlorophacinone in human plasma is reported for that purpose. Under phenobarbital 200 mg/day, chlorophacinone exhibited an apparent elimination half-life (3.27 days) shorter than in previously reported cases. If PI is useful for planning phytomenadione treatment and used for therapeutic monitoring of AVK, the chlorophacinone concentrations follow-up may provide a better estimation of the duration of hospitalisation. Chlorophacinone accumulation in target cells or existence of an unidentified metabolite may explain persistence of the hypocoagulability syndrome at low plasmatic concentrations of chlorophacinone. This case illustrates how toxicological management may facilitate toxicokinetics and therapeutic data acquisition.
authors.affiliation: Department of Clinical Pharmacology and Toxicology, Poison Control Center, Hôpital Pellegrin, Bordeaux, France. fabrice.lagrange@pharmaco.u-bordeaux2.fr
authors.forename: F
authors.initials: F
authors.lastname: Lagrange
authors.forename: A G
authors.initials: AG
authors.lastname: Corniot
authors.forename: K
authors.initials: K
authors.lastname: Titier
authors.forename: R
authors.initials: R
authors.lastname: Bedry
authors.forename: F
authors.initials: F
authors.lastname: Pehourcq
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000097:blood* / Q000506:poisoning*; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D002851:Chromatography, High Pressure Liquid; D016903:Drug Monitoring / Q000379:methods*; D062787:Drug Overdose / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy; D004638:Emergency Treatment / Q000379:methods*; D006801:Humans; D007189:Indans / Q000097:blood* / Q000506:poisoning*; D008297:Male; D015813:Substance Abuse Detection / Q000379:methods*; D013406:Suicide, Attempted; D010837:Vitamin K 1 / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D007189:Indans; C004662:chlorophacinone; D010837:Vitamin K 1